Markets:

Overview

News

Currencies

International

Treasuries

Brainstorm Cell Therapeutics Inc. - Common Stock (NQ:BCLI)

1.170 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Brainstorm Cell Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 10, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 24, 2024

Via Benzinga

BCLI Stock Earnings: Brainstorm Cell Reported Results for Q1 2024 ↗

May 14, 2024

Brainstorm Cell just reported results for the first quarter of 2024.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

May 01, 2024

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news for Wednesday morning!

Via InvestorPlace

Brainstorm Cell: Q4 Earnings Insights ↗

April 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 09, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 09, 2024

Pre-market stock movers are worth checking out as we get into all of the hottest news investors need to know about on Tuesday morning!

Via InvestorPlace

Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket ↗

April 09, 2024

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

Via Benzinga

BCLI Stock Earnings: Brainstorm Cell Beats EPS for Q4 2023 ↗

April 01, 2024

BCLI stock results show that Brainstorm Cell beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 25, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 20, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 21, 2024

Via Benzinga

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 25, 2024

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 19, 2024

Via Benzinga

BioRestorative Therapies Presents Promising Data At Orthopaedic Research Society (ORS) 2024 Annual Meeting ↗

February 13, 2024

BioRestorative Therapies (NASDAQ: BRTX) is a clinical-stage biotech company that is developing cell-based therapies to treat chronic lumbar disc disease and metabolic conditions such as obesity and...

Via Benzinga

Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 30, 2024

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 12, 2024

Via Benzinga

BCLI DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - BCLI

January 02, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

BCLI FINAL DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important January 2 Deadline in Securities Class Action Filed by the Firm – BCLI

January 01, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

BCLI FINAL DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important January 2 Deadline in Securities Class Action Filed by the Firm

December 31, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

BRAINSTORM CELL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the Firm

December 29, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

BCLI FINAL DEADLINE ALERT: ROSEN, THE FIRST FILING FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important January 2 Deadline in Securities Class Action Initiated by the Firm - BCLI

December 29, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Brainstorm Cell, SolarEdge, and Barclays and Encourages Investors to Contact the Firm

December 28, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

BCLI DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action Commenced by the Firm – BCLI

December 28, 2023

From The Rosen Law Firm PA

Via GlobeNewswire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Brainstorm Cell Therapeutics Inc. (BCLI)

December 28, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses to Secure Counsel Before Important January 2 Deadline in Securities Class Action First Filed by the Firm - BCLI

December 27, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.